Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study

NCT01865162 is registered in ClinicalTrials.gov with Mid-Atlantic Epilepsy and Sleep Center, LLC as lead sponsor.

NCT NCT01865162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01865162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Lead sponsor
Mid-Atlantic Epilepsy and Sleep Center, LLC
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2021
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme